SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst an intense community debate surrounding the Trump administration's "war with Iran," with proponents celebrating decisive actions against a perceived terrorist threat, while detractors highlight escalating global tensions, rising gas prices, and alleged distractions from other controversial matters.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending amid escalating Middle East tensions, with recent reports of targeted oil facility bombings and concerns over Strait of Hormuz disruptions driving intense community discussion. Investors are actively debating the potential for sustained higher oil prices and the broader economic ramifications of the ongoing conflict.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is gaining traction as escalating conflict in the Middle East, marked by attacks on key oil infrastructure and disruptions in the Strait of Hormuz, fuels community concern over potential prolonged supply shortages and a significant rally in crude oil prices.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending amid discussions of its recent integration with Coinbase's DEX, with the community highlighting its multi-chain presence across Solana, Base, and Cronos, alongside an active burning mechanism and a strong organic following.

ProShares Trust - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is seeing intense discussion and price action driven by escalating geopolitical tensions in the Middle East, particularly concerning Iran and the critical Strait of Hormuz. The community is actively speculating on potential crude oil supply disruptions, with many anticipating a significant rally for oil prices.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending due to significant integrations, including providing real-time data to Sui's DeFi ecosystem and a notable partnership with the U.S. Commerce Department to publish economic data on-chain. The community is actively discussing its strong utility in the Real-World Asset (RWA) sector and the impact of its ongoing token buyback program, often contrasting its fundamental value against meme coin performance.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

The upcoming March 12 Investor Day is driving significant conversation for Lucid, as investors eagerly await details on its new mid-size EV platform and potential partnerships, sparking hopes for a short squeeze given high short interest. However, community sentiment remains deeply divided following mixed earnings that showed strong revenue growth but wider losses and a recent workforce reduction, leading to ongoing concerns about cash burn and future dilution.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is trending as a recent acquisition in the biotech space fuels optimism for further M&A, while community discussion highlights perceived positive shifts in FDA leadership and a potential for short squeezes, positioning the sector as a resilient play amid broader market uncertainty.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox Enterprises is trending after securing a substantial $2.4 billion contract with Base Electron, backed by Applied Digital, to deliver 1.2 GW of natural gas-fired power generation for AI data centers. The community views this as a transformational deal, positioning the company as a crucial provider of rapid energy solutions for the booming AI infrastructure sector.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as the community eagerly anticipates AACR 2026, where its full Steering Committee, composed of leading oncologists, will co-author an abstract, signaling high confidence in the FLAMINGO-01 trial's efficacy. This, coupled with increased patient screening rates and the company's strong financial position, fuels significant discussion about potential positive interim data, a looming short squeeze, and a substantial revaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GW&K Investment Management LLC Sells 184,823 Shares of Ionis Pharmaceuticals, Inc. $IONS

GW&K Investment Management LLC lessened its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 41.2% during the third quarter, according to its most recent filing with the Securities...

DCF Advisers LLC Has $7.09 Million Stock Holdings in Ionis Pharmaceuticals, Inc. $IONS

DCF Advisers LLC lifted its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 18.2% in the third quarter, according to the company in its most recent filing with the...

Allene Diaz Sells 54,878 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) Director Allene Diaz sold 54,878 shares of the business's stock in a transaction on Tuesday, March 3rd. The stock was sold at an average...

C Frank Bennett Sells 85,089 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP C Frank Bennett sold 85,089 shares of the firm's stock in a transaction dated Tuesday, March 3rd. The stock was sold at an average...

Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 20,106 Shares of Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Shannon Devers sold 20,106 shares of the company's stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at...

ARK Investment Management LLC Decreases Holdings in Ionis Pharmaceuticals, Inc. $IONS

ARK Investment Management LLC lowered its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 29.9% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Amova Asset Management Americas Inc. Decreases Holdings in Ionis Pharmaceuticals, Inc. $IONS

Amova Asset Management Americas Inc. lessened its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 18.0% during the third quarter, according to its most recent filing with the...

Legato Capital Management LLC Takes Position in Ionis Pharmaceuticals, Inc. $IONS

Legato Capital Management LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities...

American Century Companies Inc. Grows Position in Ionis Pharmaceuticals, Inc. $IONS

American Century Companies Inc. raised its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 190.3% during the 3rd quarter, according to the company in its most recent 13F...

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $104.00 at Leerink Partners

Leerink Partners increased their price objective on Ionis Pharmaceuticals from $102.00 to $104.00 and gave the stock an "outperform" rating in a research report on Tuesday...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Current Price	$74.04
Prev Close	$75.16
Open	$73.97
Dividend Yield	0.00%
50-Day Moving Average	$81.16
Beta	0.71
Avg. Volume	2.15M
PE Ratio	-30.02

52-Week High	$86.74
52-Week Low	$23.95
Market Capitalization	$12.23B
EPS (Annual)	-$2.38
Price to Book	24.72
Revenue Per Employee	$673,117.69

IONS
Ionis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IONS News

IONSIonis Pharmaceuticals Inc